Barrington Research Reiterates Outperform Rating for HealthEquity (NASDAQ:HQY)

Barrington Research reiterated their outperform rating on shares of HealthEquity (NASDAQ:HQY - Free Report) in a research report released on Friday,Benzinga reports. Barrington Research currently has a $112.00 price target on the stock.

A number of other equities analysts have also weighed in on the company. KeyCorp decreased their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Monday, March 24th. The Goldman Sachs Group dropped their target price on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Wells Fargo & Company increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $112.58.

HealthEquity Price Performance

NASDAQ HQY traded down $0.33 on Friday, hitting $83.03. The stock had a trading volume of 644,192 shares, compared to its average volume of 1,027,934. The firm has a 50-day moving average of $97.05 and a 200-day moving average of $96.45. The company has a market capitalization of $7.18 billion, a price-to-earnings ratio of 76.17, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity has a 52-week low of $65.01 and a 52-week high of $115.59.

Remove Ads

Insider Activity

In other news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,381 shares of company stock valued at $1,781,432. Insiders own 2.20% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Wealthfront Advisers LLC bought a new position in HealthEquity in the fourth quarter worth $10,304,089,000. T. Rowe Price Investment Management Inc. purchased a new position in HealthEquity during the 4th quarter valued at about $78,107,000. Norges Bank purchased a new position in HealthEquity during the 4th quarter valued at about $74,701,000. Raymond James Financial Inc. bought a new stake in HealthEquity during the fourth quarter worth about $45,728,000. Finally, Iron Triangle Partners LP purchased a new stake in HealthEquity in the fourth quarter worth about $32,202,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.